Diltiazem Safety Profile & Adverse Events

Safety Profile Overview

Non-dihydropyridine calcium channel blocker for hypertension, angina, and rate control. Important drug interactions with statins.

Generic Name

diltiazem hydrochloride

Brand Names

Cardizem, Tiazac

Therapeutic Class

Calcium Channel Blocker

Manufacturer

Various

What Pharma Signal Tracks for Diltiazem

Adverse Events (FAERS) — All FDA Adverse Event Reporting System reports mentioning Diltiazem, including serious outcomes, hospitalizations, and deaths.
FDA Recalls — Class I, II, and III recalls, market withdrawals, and safety alerts related to Diltiazem products.
Label Changes — Boxed warning additions, new contraindications, dosing modifications, and safety-related labeling supplements.
Risk Score — Composite risk score (0–100) combining adverse event rates, recall history, and label severity with explainable breakdown.
Pharmacovigilance Signals — Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) analysis detecting disproportionate adverse reactions.
Trend Analysis — Monthly time series with anomaly detection for emerging safety signals.

Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.

Get Diltiazem Safety Data via API

One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Diltiazem.

curl "https://api.pharma-signal.com/drug/safety/diltiazem" \
  -H "X-API-Key: your_key"

# Returns risk score, adverse event counts,
# serious/death rates, recalls, and signals

Try the API API Reference

Related Safety Intelligence

Pharma Signal provides comparative analysis across therapeutic classes. Compare Diltiazem against other Calcium Channel Blocker drugs, or explore the full manufacturer portfolio for Various.

Head-to-head comparison — Compare up to 5 drugs side by side on all safety metrics.
Therapeutic class benchmarking — See how Diltiazem ranks within Calcium Channel Blocker on serious event rates.
Company portfolio risk — View all drugs from Various with aggregate risk exposure.
AI analyst briefs — Get a natural-language safety assessment combining all data sources.